Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
企業コードNOTV
会社名Inotiv Inc
上場日Nov 25, 1997
最高経営責任者「CEO」Mr. Robert W. Leasure, Jr.
従業員数1977
証券種類Ordinary Share
決算期末Nov 25
本社所在地2701 Kent Ave
都市WEST LAFAYETTE
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号47906-1382
電話番号13174634527
ウェブサイトhttps://www.inotiv.com/
企業コードNOTV
上場日Nov 25, 1997
最高経営責任者「CEO」Mr. Robert W. Leasure, Jr.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし